Table 1.
Clinicopathologic characteristics of the study cohort
| Variables | Number (%) |
|---|---|
| Total | 84 |
| Healthy control | 36 (42.9) |
| Age (years) | |
| Mean ± SD | 45.4 ± 14.0 |
| Range | 24–78 |
| Gender | |
| Male | 10 (27.8) |
| Female | 26 (72.2) |
| Uveal Melanoma | 48 (57.1) |
| Age (years)* | |
| Mean ± SD | 61.8 ± 13.6 |
| Range | 25–88 |
| Gender | |
| Male | 29 (60.4) |
| Female | 17 (35.4) |
| NA | 2 (4.2) |
| Cell type | |
| Spindle | 8 (16.7) |
| Mixed | 25 (52.1) |
| Epithelioid | 5 (10.4) |
| NA | 10 (20.8) |
| Metastasis status | |
| Met | 14 (29.2) |
| DF | 9 (18.8) |
| NA | 25 (52.1) |
NA, relevant clinicopathologic information not available or shorter surveillance follow-up. Met, patients who died with clinically overt metastases from uveal melanoma. DF, patients who were disease-free for at least 5 years following treatment of the primary tumor
*2 patients without relevant information